Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,282Revenue $M1,407Net Margin (%)47.1Altman Z-Score8.6
Enterprise Value $M4,390EPS $13.0Operating Margin %51.3Piotroski F-Score7
P/E(ttm)8.9Beneish M-Score-2.5Pre-tax Margin (%)75.6Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %55.8Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow13.6y-y EBITDA Growth Rate %227ROA % (ttm)34.0Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)55.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.6ROIC % (ttm)71.6Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 115.75-21%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 115.75-28%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 115.75-28%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 115.75-28%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 115.75-36%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 115.75-36%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 115.75-24%Reduce -9.91%291,077
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 115.75-24%New holding2,450
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 115.75-24%Add 3.44%372,580
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 115.75-10%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 115.7513%Reduce -55.36%288,401
UTHRFirst Eagle Investment 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 115.7513%New holding262,080
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 115.7520%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 115.7513%Add 62.64%316,489
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 115.7529%Reduce -47.71%194,595
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 115.7558%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 115.7558%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 115.7580%Add 15.34%341,330
UTHRJoel Greenblatt 2013-03-31 Add0.02%$51.64 - $62.57
($56.61)
$ 115.75104%Add 2.24%295,921
UTHRVanguard Health Care Fund 2013-03-31 Reduce-0.02%$51.64 - $62.57
($56.61)
$ 115.75104%Reduce -11.23%1,320,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DWEK RAYMONDDirector 2016-02-04Sell3,000$122.66-5.63view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-02-04Sell5,547$122.13-5.22view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-01-28Sell5,546$124-6.65view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-01-21Sell5,547$127-8.86view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-01-14Sell5,546$135.94-14.85view
DWEK RAYMONDDirector 2016-01-07Sell3,000$143.75-19.48view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-01-07Sell5,547$145.84-20.63view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-12-24Sell5,546$159.58-27.47view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-12-17Sell5,546$158.49-26.97view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-12-10Sell5,546$154.49-25.08view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
John Hussman's Third Quarter Top 5 Nov 07 2013 
Vanguard Health Care Fund Selling Update Oct 30 2013 
Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 

More From Other Websites
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS... Feb 03 2016
4 Top-Ranked Biotech Stocks on Sale Feb 02 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Feb 01 2016
United Therapeutics settles patent dispute with Teva Pharmaceuticals Jan 19 2016
The Zacks Analyst Blog Highlights: Aerie Pharmaceuticals, United Therapeutics, Pacira... Jan 19 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Other Events Jan 19 2016
United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : January 6, 2016 Jan 06 2016
United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : January 6, 2016 Jan 06 2016
United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference Jan 06 2016
United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference Jan 06 2016
8 Biotech Stocks That Should Be in Your Portfolio Right Now Dec 23 2015
UNITED THERAPEUTICS CORP Financials Dec 08 2015
SteadyMed Demonstrates Potential for Reduced Infusion Site Sensitivity Associated With Trevyent... Dec 07 2015
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors Dec 01 2015
Hedge Funds Are Selling YPF SA (ADR) (YPF) Dec 01 2015
How Smart Money Is Trading United Therapeutics Corporation (UTHR) Nov 24 2015
United Therapeutics Stock: What is the Social Media Crowd Thinking About UTHR? Nov 11 2015
An Overview of QUAL’s Holdings Nov 06 2015
Clinigen Group and United Therapeutics Initiate Managed Access Program for UNITUXIN™ (Dinutuximab)... Nov 04 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK